Last reviewed · How we verify

NCT04836637: RENEW

ValoRization of Dairy Sidestreams to Fight Calcium dEficits iN Postmenopausal Women

Completed NA Last updated 6 October 2023
What this trial tests

NA trial testing Maltodextrin in Osteoporosis, Postmenopausal in 420 participants. Completed in 4 July 2023.

Timeline
17 May 2021
Primary endpoint
4 July 2023
4 July 2023

Quick facts

Lead sponsorUniversity of Copenhagen
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment420
Start date17 May 2021
Primary completion4 July 2023
Estimated completion4 July 2023
Sites2 locations across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Copenhagen

Who can join

Adults 45 to 75, female only, with Osteoporosis, Postmenopausal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to investigate the effects of 12-months supplementation with calcium-enriched permeate, taken alone or in conjunction with inulin, on changes in markers of bone formation and resorption and in bone mass density (BMD) in apparently healthy postmenopausal women compared with calcium-carbonate or maltodextrin supplementation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of a 1-year calcium-enriched permeate supplement on bone health in postmenopausal females: The RENEW randomized controlled intervention trial.
    Tetens I, Kisi SB, Parlesak A, Rasmussen SI, et al · · 2026 · PMID 42097280 · DOI 10.1016/j.ajcnut.2026.101339

Verify or expand the search:

Other trials of Maltodextrin

Trials testing the same drug.

Other recruiting trials for Osteoporosis, Postmenopausal

Currently open trials in the same condition.

Other University of Copenhagen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04836637.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing